Future studies involving targeted modulation of PDH expression in vivo, such as through adeno-associated virus (AAV)-mediated hepatocyte-specific overexpression or knockdown, are warranted to further validate the causal role of PDH in regulating hepatic uric acid production and hyperuricemia. This evidence concerns the gene PDP1 and hyperuricemia.